CelLBxHealth plc (FRA:DWV)
0.0120
+0.0005 (4.35%)
At close: Dec 5, 2025
CelLBxHealth Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 5.27 | 10.43 | 16.22 | 31.9 | 31.84 | 12.08 | Upgrade
|
| Short-Term Investments | - | - | - | - | - | 16.54 | Upgrade
|
| Cash & Short-Term Investments | 5.27 | 10.43 | 16.22 | 31.9 | 31.84 | 28.62 | Upgrade
|
| Cash Growth | -70.53% | -35.72% | -49.15% | 0.18% | 11.25% | 52.50% | Upgrade
|
| Accounts Receivable | 1.68 | 0.77 | 0.73 | 0.34 | 0.26 | 0.27 | Upgrade
|
| Other Receivables | 1.34 | 2.61 | 1.84 | 3.37 | 4.92 | 2.72 | Upgrade
|
| Receivables | 3.03 | 3.38 | 2.57 | 3.71 | 5.17 | 2.99 | Upgrade
|
| Inventory | 1.57 | 1.58 | 1.68 | 2.06 | 1.75 | 0.74 | Upgrade
|
| Prepaid Expenses | - | 1.02 | 0.75 | 0.96 | 0.61 | 0.58 | Upgrade
|
| Total Current Assets | 9.87 | 16.41 | 21.22 | 38.63 | 39.37 | 32.93 | Upgrade
|
| Property, Plant & Equipment | 5.59 | 6.4 | 7.23 | 8.48 | 4.38 | 2.41 | Upgrade
|
| Goodwill | - | 2.21 | 2.21 | 2.21 | 2.21 | 2.21 | Upgrade
|
| Other Intangible Assets | 2.63 | 0.43 | 0.51 | 0.52 | 1.32 | 1.38 | Upgrade
|
| Long-Term Deferred Charges | - | 0.01 | 0.02 | 0.03 | 0.04 | 0.12 | Upgrade
|
| Total Assets | 18.08 | 25.46 | 31.18 | 49.87 | 47.32 | 39.05 | Upgrade
|
| Accounts Payable | 2.2 | 0.7 | 1.06 | 1.5 | 1.12 | 1.09 | Upgrade
|
| Accrued Expenses | - | 1.14 | 1.33 | 1.77 | 2.22 | 1.83 | Upgrade
|
| Current Portion of Leases | 0.86 | 0.86 | 0.65 | 0.66 | 0.52 | 0.43 | Upgrade
|
| Current Income Taxes Payable | - | 0.35 | 0.31 | 0.66 | 1.01 | 0.4 | Upgrade
|
| Other Current Liabilities | 0.09 | 0.21 | 0.6 | 0.66 | 0.04 | 0.03 | Upgrade
|
| Total Current Liabilities | 3.15 | 3.26 | 3.94 | 5.25 | 4.91 | 3.78 | Upgrade
|
| Long-Term Leases | 2.81 | 3.35 | 3.91 | 4.34 | 1.82 | 0.93 | Upgrade
|
| Other Long-Term Liabilities | 0.43 | 0.41 | 0.4 | 0.22 | 0.26 | - | Upgrade
|
| Total Liabilities | 6.39 | 7.02 | 8.24 | 9.81 | 6.99 | 4.71 | Upgrade
|
| Common Stock | 32.26 | 32.26 | 26.06 | 26.06 | 23.51 | 21.54 | Upgrade
|
| Additional Paid-In Capital | 118.36 | 118.36 | 115.92 | 115.92 | 99.41 | 81.53 | Upgrade
|
| Retained Earnings | -142.17 | -133.15 | -122.33 | -103.7 | -83.81 | -69.14 | Upgrade
|
| Comprehensive Income & Other | 3.24 | 0.96 | 3.29 | 1.79 | 1.22 | 0.41 | Upgrade
|
| Total Common Equity | 11.69 | 18.44 | 22.94 | 40.06 | 40.33 | 34.34 | Upgrade
|
| Shareholders' Equity | 11.69 | 18.44 | 22.94 | 40.06 | 40.33 | 34.34 | Upgrade
|
| Total Liabilities & Equity | 18.08 | 25.46 | 31.18 | 49.87 | 47.32 | 39.05 | Upgrade
|
| Total Debt | 3.67 | 4.21 | 4.55 | 5 | 2.34 | 1.36 | Upgrade
|
| Net Cash (Debt) | 1.6 | 6.22 | 11.66 | 26.9 | 29.5 | 27.26 | Upgrade
|
| Net Cash Growth | -88.26% | -46.72% | -56.63% | -8.83% | 8.24% | 58.34% | Upgrade
|
| Net Cash Per Share | 0.00 | 0.02 | 0.04 | 0.11 | 0.13 | 0.15 | Upgrade
|
| Filing Date Shares Outstanding | 322.64 | 321.53 | 260.47 | 260.47 | 235.03 | 215.29 | Upgrade
|
| Total Common Shares Outstanding | 322.64 | 322.53 | 260.47 | 260.47 | 235.03 | 215.29 | Upgrade
|
| Working Capital | 6.72 | 13.15 | 17.27 | 33.38 | 34.45 | 29.15 | Upgrade
|
| Book Value Per Share | 0.04 | 0.06 | 0.09 | 0.15 | 0.17 | 0.16 | Upgrade
|
| Tangible Book Value | 9.06 | 15.81 | 20.22 | 37.33 | 36.8 | 30.76 | Upgrade
|
| Tangible Book Value Per Share | 0.03 | 0.05 | 0.08 | 0.14 | 0.16 | 0.14 | Upgrade
|
| Machinery | - | 5.03 | 5.18 | 4.93 | 4.18 | 2.96 | Upgrade
|
| Leasehold Improvements | - | 1.98 | 1.91 | 1.93 | 0.88 | 0.49 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.